Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background/Aims: This study aimed to characterize the changes in the gut microbiota of irritable bowel syndrome (IBS) patients and to investigate the consequent alterations in bacterial functions. Methods: We performed 16S rRNA metagenomic sequencing and a phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) analyses using fecal samples from control (n=12) and diarrhea-dominant IBS patients (n=7). Results: The samples were clustered by the principal coordinates analysis depending on the presence of IBS (p=0.003). In the IBS patients, the abundances of Acidaminococcaceae, Sutterellaceae, and Desulfovibrionaceae were significantly increased, while those of Enterococcaceae, Leuconostocaceae, Clostridiaceae, Peptostreptococcaceae, and Lachnospiraceae were significantly decreased. The PICRUSt results indicated that two orthologues involved in secondary bile acid biosynthesis were significantly decreased in IBS patients. Modules involved in multidrug resistance, lipopolysaccharide biosynthesis, the reductive citrate cycle, and the citrate cycle were significantly increased in the IBS patients. In contrast, modules involved in cationic antimicrobial peptide resistance, and some transport systems were more abundant in controls than in IBS patients. Conclusions: Changes in the gut microbiota composition in IBS patients lead to alterations in bacterial functions, such as bile acid transformation and the induction of inflammation, which is a known pathophysiological mechanism of IBS.
Abstract
Background/Aims: This study aimed to characterize the changes in the gut microbiota of irritable bowel syndrome (IBS) patients and to investigate the consequent alterations in bacterial functions. Methods: We performed 16S rRNA metagenomic sequencing and a phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) analyses using fecal samples from control (n=12) and diarrhea-dominant IBS patients (n=7). Results: The samples were clustered by the principal coordinates analysis depending on the presence of IBS (p=0.003). In the IBS patients, the abundances of Acidaminococcaceae, Sutterellaceae, and Desulfovibrionaceae were significantly increased, while those of Enterococcaceae, Leuconostocaceae, Clostridiaceae, Peptostreptococcaceae, and Lachnospiraceae were significantly decreased. The PICRUSt results indicated that two orthologues involved in secondary bile acid biosynthesis were significantly decreased in IBS patients. Modules involved in multidrug resistance, lipopolysaccharide biosynthesis, the reductive citrate cycle, and the citrate cycle were significantly increased in the IBS patients. In contrast, modules involved in cationic antimicrobial peptide resistance, and some transport systems were more abundant in controls than in IBS patients. Conclusions: Changes in the gut microbiota composition in IBS patients lead to alterations in bacterial functions, such as bile acid transformation and the induction of inflammation, which is a known pathophysiological mechanism of IBS.
참고문헌 (40)
- Mearin F, "Bowel disorders", Gastroenterology, 150, pp.1393~1407 (2016)
- Camilleri M, "Irritable bowel syndrome : pathophysiology and current therapeutic approaches", Handb Exp Pharmacol, 239, pp.75~113 (2017)
- Bhattarai Y, "Irritable bowel syndrome: a gut microbiota-related disorder?", Am J Physiol Gastrointest Liver Physiol, 312, pp.G52~ (2017)
- Saulnier DM, "Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome", Gastroenterology, 141, pp.1782~1791 (2011)
- Jeffery IB, "An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota", Gut, 61, pp.997~1006 (2012)
- Tap J, "Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome", Gastroenterology, 152, pp.111123~ (2017)
- Rajilić-Stojanović M, "Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome", Gastroenterology, 141, pp.1792~1801 (2011)
- Sayin SI, "Gut microbiota regulates bile acid metabolism by reducing the levels of taurobeta-muricholic acid, a naturally occurring FXR antagonist", Cell Metab, 17, pp.225~235 (2013)
- Dior M, "Interplay between bile acid metabolism and microbiota in irritable bowel syndrome", Neurogastroenterol Motil, 28, pp.1330~1340 (2016)
- 최윤진, "Association Between SLC6A4 Serotonin Transporter Gene Linked Polymorphic Region and ADRA2A −1291C>G and Irritable Bowel Syndrome in Korea", Journal of Neurogastroenterology and Motility (JNM), 20(3), pp.388~399 (2014), 대한소화기 기능성질환∙운동학회[DOI]
- Choi YJ, "Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses", J Gastroenterol Hepatol, 32, pp.1553~1561 (2017)
- Ju Yup Lee, "Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex", Journal of Neurogastroenterology and Motility (JNM), 26(1), pp.106~116 (2020), 대한소화기 기능성질환∙운동학회[DOI]
- Drossman DA, "The functional gastrointestinal disorders and the Rome III process", Gastroenterology, 130, pp.1377~1390 (2006)
- Lee SM, "Microbial changes and host response in F344 rat colon depending on sex and age following a high-fat diet", Front Microbiol, 9, pp.2236~ (2018)
- Bolger AM, "Trimmomatic : a flexible trimmer for Illumina sequence data", Bioinformatics, 30, pp.2114~2120 (2014)
- Masella AP, "PANDAseq : paired-end assembler for illumina sequences", BMC Bioinformatics, 13, pp.31~ (2012)
- Eddy SR, "Accelerated profile HMM searches", PLoS Comput Biol, 7, pp.e1002195~ (2011)
- Lee B, "DUDE-Seq : fast, flexible, and robust denoising for targeted amplicon sequencing", PLoS One, 12, pp.e0181463~ (2017)
- Edgar RC, "Search and clustering orders of magnitude faster than BLAST", Bioinformatics, 26, pp.2460~2461 (2010)
- Myers EW, "Optimal alignments in linear space", Comput Appl Biosci, 4, pp.11~17 (1988)
- Edgar RC, "UCHIME improves sensitivity and speed of chimera detection", Bioinformatics, 27, pp.2194~2200 (2011)
- Fu L, "CD-HIT : accelerated for clustering the next-generation sequencing data", Bioinformatics, 28, pp.3150~3152 (2012)
- Lozupone C, "UniFrac : a new phylogenetic method for comparing microbial communities", Appl Environ Microbiol, 71, pp.8228~8235 (2005)
- Langille MG, "Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences", Nat Biotechnol, 31, pp.814~821 (2013)
- Segata N, "Metagenomic biomarker discovery and explanation", Genome Biol, 12, pp.R60~ (2011)
- Carbonero F, "Encyclopedia of metagenomics", pp.617~619 (2015), Springer
- Malinen E, "Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR", Am J Gastroenterol, 100, pp.373~382 (2005)
- Sean M.P. Bennet, "Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome", Gut and Liver, 9(3), pp.318~331 (2015), 거트앤리버 소화기연관학회협의회
- Kakiyama G, "Modulation of the fecal bile acid profile by gut microbiota in cirrhosis", J Hepatol, 58, pp.949~955 (2013)
- Rajilić-Stojanović M, "Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?", Am J Gastroenterol, 110, pp.278~287 (2015)
- Jiang H, "Altered fecal microbiota composition in patients with major depressive disorder", Brain Behav Immun, 48, pp.186~194 (2015)
- 이창현, "The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis", Journal of Neurogastroenterology and Motility (JNM), 23(3), pp.349~362 (2017), 대한소화기 기능성질환∙운동학회[DOI]
- Labus JS, "Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome", Microbiome, 5, pp.49~ (2017)
- Smith ME, "The digestive system", pp.129~152 (2010), Churchill Livingstone
- Guo S, "Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14", Am J Pathol, 182, pp.375~387 (2013)
- Dlugosz A, "Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome", Neurogastroenterol Motil, 27, pp.1747~1754 (2015)
- Liebregts T, "Immune activation in patients with irritable bowel syndrome", Gastroenterology, 132, pp.913~920 (2007)
- Zhang P, "Structure and mechanism of energy-coupling factor transporters", Trends Microbiol, 21, pp.652~659 (2013)
- Davidson AL, "Structure, function, and evolution of bacterial ATP-binding cassette systems", Microbiol Mol Biol Rev, 72, pp.317~364 (2008)
- Pittayanon R, "Gut microbiota in patients with irritable bowel syndrome : a systematic review", Gastroenterology, 157, pp.97~108 (2019)